Home › Stocks › SABSW

SABSW — Sab Biotherapeutics Inc W Exp 10/22/202

Reported value held$12.04M
Funds holding (latest)23
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)10
Institutional value$13.56K · 968.37K sh
New / Add / Cut / Exit2 / 0 / 2 / 1 · Updated 2026-11-17
Top-5 / Top-10 concentration91.9% / 100.0%
Institutional holdings change Reducing -0.8% (-7.82K sh)
Institutional value change Up +8.4%

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 10 SEC-registered investment managers reported holding SABSW (Sab Biotherapeutics Inc W Exp 10/22/202) in their latest 13F filings, with a combined reported value of $13.56K across 968.37K shares. That is -0.8% by share count (-7.82K shares) versus the previous quarter, while reported value moved +8.4%. Ownership is concentrated: the five largest holders account for 91.9% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 2 opened new positions, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202 (SABSW) include Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, ranked by reported 13F value among the 23 institutional holders on this page.

SABSW is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 10 968.37K $13.56K -0.8%
Q2 2026 9 941.52K $12.06K +0.5%
Q1 2026 8 936.76K $24.33K -0.6%
Q4 2025 9 400.54K $12.24K -4.6%
Q3 2025 12 954.50K $22.46K -2.7%
Q2 2025 7 848.58K $28.25K +0.0%
Q1 2025 10 1.07M $34.81K -1.5%
Q4 2024 11 1.00M $75.74K -20.5%

Over the 8 quarters shown, institutional share counts decreased 4% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-20.5%).

Top Institutional Holders (Q3 2026) — 10 funds

FundSharesValuePortfolio WeightChange
LMR Partners LLP 539.59K $7.55K 0.00% Hold
Morgan Stanley 146.44K $2.05K 0.00% Hold
Clear Street Group Inc. 79.01K $1.11K 0.00% Hold
MILLENNIUM MANAGEMENT LLC 62.50K $875 0.00% Hold
Millennium Management 62.50K $875 0.00% Hold
SUSQUEHANNA INTERNATIONAL GROUP, LLP 37.91K $531 0.00% New
GTS SECURITIES LLC 33.80K $473 0.00% Reduce
UBS Group AG 6.27K $88 0.00% Reduce
TORONTO DOMINION BANK 300 $4 0.00% Hold
Tower Research Capital LLC (TRC) 48 $1 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 9 funds

FundSharesValuePortfolio WeightChange
LMR Partners LLP 539.59K $6.91K 0.00% Hold
Morgan Stanley 146.44K $1.87K 0.00% Hold
Clear Street Group Inc. 79.03K $1.01K 0.00% Hold
Millennium Management 62.50K $800 0.00% Hold
MILLENNIUM MANAGEMENT LLC 62.50K $800 0.00% Hold
GTS SECURITIES LLC 41.30K $537 0.00% Add
UBS Group AG 6.57K $85 0.00% Add
WOLVERINE ASSET MANAGEMENT LLC 3.29K $42 0.00% Add
TORONTO DOMINION BANK 300 $4 0.00% New

Q1 2026 — 8 funds

FundSharesValuePortfolio WeightChange
LMR Partners LLP 539.59K $14.08K 0.00% New
Morgan Stanley 146.44K $3.71K 0.00% Hold
Clear Street Group Inc. 78.73K $2.06K 0.00% Hold
Millennium Management 62.50K $1.63K 0.00% Hold
MILLENNIUM MANAGEMENT LLC 62.50K $1.63K 0.00% Hold
GTS SECURITIES LLC 41.00K $1.07K 0.00% Hold
UBS Group AG 4.19K $105 0.00% Reduce
WOLVERINE ASSET MANAGEMENT LLC 1.81K $47 0.00% Hold

Q4 2025 — 9 funds

FundSharesValuePortfolio WeightChange
Morgan Stanley 146.44K $4.57K 0.00% Hold
Clear Street Group Inc. 78.83K $2.46K 0.00% Hold
Millennium Management 62.50K $1.95K 0.00% Hold
MILLENNIUM MANAGEMENT LLC 62.50K $1.95K 0.00% Hold
GTS SECURITIES LLC 41.10K $1.03K 0.00% New
UBS Group AG 6.19K $192 0.00% Reduce
WOLVERINE ASSET MANAGEMENT LLC 1.81K $57 0.00% Hold
NewEdge Advisors, LLC 1.07K $33 0.00% Hold
Bank of America Corp 100 $3 0.00% Reduce

Q3 2025 — 12 funds

FundSharesValuePortfolio WeightChange
LMR Partners LLP 539.59K $12.63K 0.00% Hold
Morgan Stanley 146.44K $3.43K 0.00% Hold
Clear Street Group Inc. 79.03K $1.85K 0.00% New
MILLENNIUM MANAGEMENT LLC 62.50K $1.46K 0.00% Hold
Millennium Management 62.50K $1.46K 0.00% Hold
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26.30K $750 0.00% New
UBS Group AG 23.41K $539 0.00% New
Walleye Trading LLC 11.44K $268 0.00% Reduce
WOLVERINE ASSET MANAGEMENT LLC 1.81K $42 0.00% Reduce
NewEdge Advisors, LLC 1.07K $25 0.00% Hold
Bank of America Corp 200 $5 0.00% New
TORONTO DOMINION BANK 200 $5 0.00% New

Q2 2025 — 7 funds

FundSharesValuePortfolio WeightChange
LMR Partners LLP 539.59K $17.97K 0.00% Hold
Morgan Stanley 146.44K $4.88K 0.00% Hold
MILLENNIUM MANAGEMENT LLC 62.50K $2.08K 0.00% Hold
Millennium Management 62.50K $2.08K 0.00% Hold
Walleye Trading LLC 31.86K $1.06K 0.00% Hold
WOLVERINE ASSET MANAGEMENT LLC 4.62K $153 0.00% Hold
NewEdge Advisors, LLC 1.07K $35 0.00% Hold

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
LMR Partners LLP 539.59K 539.59K 539.59K — 539.59K 539.59K 539.59K 539.59K 539.59K 539.59K 539.59K 539.59K 539.59K — — — — — — —
Morgan Stanley 146.44K 146.44K 146.44K 146.44K 146.44K 146.44K 146.44K 146.44K 146.44K 146.44K 148.94K 148.94K 148.94K 148.94K 148.94K 148.94K 148.94K 148.94K 150.85K 31.41K
Clear Street Group Inc. 79.01K 79.03K 78.73K 78.83K 79.03K — — — — — — — — — — — — — — —
MILLENNIUM MANAGEMENT LLC 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K — — — — — — —
Millennium Management 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K 62.50K
SUSQUEHANNA INTERNATIONAL GROUP, LLP 37.91K — — — 26.30K — — — — — 12.37K — — — — — — — — —
GTS SECURITIES LLC 33.80K 41.30K 41.00K 41.10K — — — — — — — — — — — — — — — —
UBS Group AG 6.27K 6.57K 4.19K 6.19K 23.41K — — 1.63K — 56 — 29.08K — 100 — — 5.61K — — 2.89K
TORONTO DOMINION BANK 300 300 — — 200 — — — — — — — — — — — — — — —
Tower Research Capital LLC (TRC) 48 — — — — — — 48 48 48 48 48 48 — — — — — — —
Shaolin Capital Management LLC — — — — — — — — — 249.14K 292.96K 371.64K 465.72K — — — — — — —
HB Wealth Management, LLC — — — — — — 60.00K 50.00K 310.00K — — — — — — — — — — —
Yakira Capital Management, Inc. — — — — — — 78.73K 93.23K 108.48K 108.48K 108.48K 108.48K 108.48K — — — — — — —
Walleye Trading LLC — — — — 11.44K 31.86K 31.86K 38.76K 15.51K 15.51K 15.51K 15.51K 15.51K — — — — — — —
Tabor Asset Management, LP — — — — — — 78.73K — — — — — — — — — — — — —
Walleye Capital LLC — — — — — — — — 23.26K 23.26K 23.26K 23.26K 23.26K — — — — — — —
WOLVERINE ASSET MANAGEMENT LLC — 3.29K 1.81K 1.81K 1.81K 4.62K 4.62K 8.65K 15.52K 15.32K 22.78K 22.81K 12.77K — — — — — — —
NewEdge Advisors, LLC — — — 1.07K 1.07K 1.07K 1.07K 1.07K 1.07K 1.07K 1.07K 1.07K 1.07K — — — — — — —
Bank of America Corp — — — 100 200 — — — — 200 100 — — — — — — — — —
Balyasny Asset Management — — — — — — — — — — — — — — 281.11K 281.11K 281.11K 281.11K 281.11K 281.11K

Download holders (CSV)

FAQ

Which funds hold SABSW?

As of 2026-Q3, 10 institutional funds reported holding SABSW (Sab Biotherapeutics Inc W Exp 10/22/202) in SEC 13F filings, with a combined reported value of $13.56K.

How many shares of SABSW do institutions own?

13F filers reported 968.37K shares of SABSW, worth $13.56K in aggregate at the end of 2026-Q3.

Is institutional ownership of SABSW rising or falling?

Share counts moved -0.8% versus the prior quarter — distribution.

Who are the top institutional holders of SABSW?

The largest 13F holders are Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, Balyasny Asset Management, LMR Partners LLP; the top 25 are ranked at the top of this page.

Who are the major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202?

The major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202 (SABSW) by reported 13F value are Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, Balyasny Asset Management, LMR Partners LLP, among 23 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own SABSW" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/SABSW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →